Multiple sclerosis (MS) is far more than a neurological disease, and emerging science shows the gut may play a larger role than anyone expected.

In this episode of Biome Breakthrough, Dr. Shaina Cahill and Jason Klop discuss how gut dysbiosis, chronic inflammation, immune imbalance, and microbiome disruption may contribute to MS progression, symptom severity, and long-term outcomes.

They explore:

• Why MS involves the gut, immune system, and brain
• How leaky gut, altered barrier integrity, and inflammation can activate microglia in the CNS
• The striking consistency of microbiome abnormalities in MS
• Why early intervention could dramatically change long-term outcomes
• Real patient stories showing rapid neurological and emotional improvements
• The surprising results from early FMT studies in MS
• How future medicine may use the microbiome as both a biomarker and a therapeutic

It highlights why the gut microbiome is rapidly becoming a central focus in research on neurodegenerative and autoimmune diseases.

Want to learn more or collaborate on clinical cases or research?

Connect with us at Novel Biome:

Email: support@novelbiome.com

Visit: www.novelbiome.com

Subscribe for more episodes exploring the microbiome, chronic disease, and the future of FMT.

Small intestinal bacterial overgrowth, or SIBO, affects millions and is often mistaken for IBS. It leaves patients stuck in cycles of bloating, discomfort, and uncertainty. In this episode of Biome Breakthroughs, Shaina and Jason explain the IBS and SIBO connection, what drives hydrogen and methane SIBO, and how the gut microbiome plays a much larger role in SIBO treatment than many realize. It is a conversation that blends clinical experience with emerging research to clarify a condition that can be deeply disruptive to daily life.

They explore why conventional SIBO treatment approaches often fail or lead to rapid relapse, emphasizing how restrictive diets and repeated antibiotic use can worsen post-antibiotic gut imbalance. Many patients improve temporarily, only to see symptoms return. Shaina and Jason discuss evidence that the root microbial imbalance often begins in the large intestine before spreading to the small intestine, creating the environment for bacterial overgrowth.

The episode also looks at how microbiome restoration for SIBO may offer new hope for chronic or treatment-resistant cases. Approaches such as fecal microbiota transplantation (FMT) may help rebuild microbial diversity, support gut motility, and reduce inflammation.

For patients, this episode offers clarity, especially for those who have felt stuck in recurring symptoms or have been told their condition is simply IBS. For medical professionals, it raises important questions about how to address the root microbial imbalance that drives chronic SIBO. Together, these insights show why examining the entire gut ecosystem is essential for lasting recovery.

Ready to take gut health further? Subscribe now and hit the bell to stay updated on the latest breakthroughs in microbiome science and FMT.

Join the conversation: Have thoughts on SIBO or microbiome care? Leave your questions or experiences in the comments so we can bring more of the answers you’re looking for.

🔗 Explore more resources:

• Learn about our clinical work: https://novelbiome.com
• Read our latest blogs: https://novelbiome.com/blogs
• Connect with us on LinkedIn: https://www.linkedin.com/company/novel-biome/posts/

Disclaimer: Novel Biome is a contract manufacturer of FMT products, providing high-quality FMT products to physicians. The information provided should not be considered medical advice and is based on available research and the understanding of the gut microbiome. If you have more questions, comments, or concerns, please email us at support@novelbiome.com

Autoimmune diseases reach far beyond the physical body.

In this episode of Biome Breakthroughs, Shaina and Emma talk about what it’s really like to live with autoimmune disease, and why so much of it begins in the gut. Emma shares her own experience, six years into her diagnosis with rheumatoid arthritis, and it’s not the kind of story you usually hear in medical discussions.

At Novel Biome, we’ve found that autoimmune diseases are not just the body attacking itself, but rather a loss of balance, communication, and trust between systems that are meant to work in harmony. The gut plays a central role in that balance. When 70% of your immune system sits there, the gut becomes more than digestion; it becomes your body’s first line of defense, and sometimes, its quietest cry for help. Through microbiome restoration and FMT, we’re beginning to understand how reintroducing gut diversity can change how autoimmune diseases behave.

Here, we look beneath the surface, where women carry pain that hides in plain sight, where science catches up to their stories, and where the gut quietly waits, holding clues the body has been whispering for years. If you’ve ever felt unheard in your journey with an autoimmune disease, or if you’re a clinician seeking deeper insight, this conversation is for you. It’s not just science; it’s a reminder that healing begins when we listen to the body, the gut, and to each other.

Related Research

Fecal microbiota transplantation for rheumatoid arthritis: A case report by Zeng et al., 2020

🔗 Read the study here: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.3677

Ready to explore more on the gut–immune connection? Subscribe to Biome Breakthroughs (https://novelbiome.podbean.com/) for the latest on microbiome science, patient stories, and clinical research from Novel Biome

Join the discussion: share your experiences with autoimmune disease and microbiome-based treatments in the comments.

🌐 Explore more: Clinical insights: https://novelbiome.com Research and blogs: https://novelbiome.com/blogs Connect with us on LinkedIn:https://www.linkedin.com/company/novel-biome/posts/

#AutoimmuneDisease #GutHealth #NovelBiome #BiomeBreakthroughs #MicrobiomeBasedTherapy #MedicalInnovation #FutureOfMedicine #ScienceMeetsHealing #PreventiveHealth #MicrobiomeMatters #GutImmuneAxis #MicrobialHealth

Osteoporosis is a condition that touches millions of lives, often in ways that people only notice when it is too late. In this episode of Biome Breakthroughs, Shaina and Jason share a surprising study that explores how the gut microbiome may help protect against osteoporosis. It is a story that brings science and lived experience together, showing how something deep inside the gut can shape the strength of our bones.

The research used a model of postmenopausal osteoporosis and revealed something remarkable. When mice received daily fecal microbiota transplantation (FMT), they showed stronger bones, less inflammation, and healthier gut barriers. Instead of watching bone density slowly disappear, FMT appeared to help restore balance, prevent bone loss, and even encourage new bone formation. It is early research, but it opens a door to new thinking about osteoporosis care.

Osteoporosis has long been seen as a disease of aging bones, but this study reminds us that the story is bigger. It involves the immune system, inflammation, metabolism, and the gut microbiome. By paying attention to the gut, we may have another tool to slow down or even prevent the rapid bone loss many women face after menopause.

For patients, this episode offers hope. For medical professionals, it raises questions about how to use microbiome care as part of osteoporosis treatment and prevention. Together, these insights show why the gut cannot be ignored when we talk about bone health.

Ready to take gut health further? Subscribe now and hit the bell to stay updated on the latest breakthroughs in microbiome science and FMT.

Join the conversation: Drop your questions or share your experiences with osteoporosis and microbiome-based treatments in the comments. Your insights help shape our future episodes.

🔗 Explore more resources:

• Learn about our clinical work: https://novelbiome.com
• Read our latest blogs: https://novelbiome.com/blogs
• Connect with us on LinkedIn: https://www.linkedin.com/company/novel-biome/posts/

#Osteoporosis #BoneHealth #PostmenopausalHealth #GutBoneAxis #AgingAndHealth

#FMT #FecalMicrobiotaTransplant #GutMicrobiome #MicrobiomeResearch #MedicalBreakthrough #HealthcareProfessionals #PatientCare #WomensHealth #ChronicConditions #PreventiveHealth

Inflammatory Bowel Disease (IBD) affects millions of people, often leaving them caught between painful symptoms and treatments that do not always last. In this episode of Biome Breakthroughs, Shaina and Jason break down why Fecal Microbiota Transplantation (FMT) is becoming one of the most promising options for IBD, and specifically ulcerative colitis.

You will hear how FMT restores balance in the gut microbiome, why donor quality can change outcomes, and how new approaches like capsules and longer treatment protocols are improving remission rates. With real patient stories and medical insights, this conversation explores how IBD care is evolving beyond steroids and biologics.

Inflammatory Bowel Disease is not simple, but there is hope. For patients and professionals alike, this episode opens the door to a future where FMT may soon be a standard part of treatment.

Ready to take gut health further? Subscribe now and hit the bell to stay updated on the latest breakthroughs in microbiome science and FMT.

Join the conversation: Drop your questions or share your experiences with Inflammatory Bowel Disease (IBD) and microbiome-based treatments in the comments. Your insights help shape our future episodes.

Explore more resources:

• Learn about our clinical work: https://novelbiome.com
• Read our latest blogs: https://novelbiome.com/blog
• Connect with us on LinkedIn: https://www.linkedin.com/company/novelbiome

#InflammatoryBowelDisease #IBD #UlcerativeColitis #CrohnsDisease #GutHealth #FecalMicrobiotaTransplant #FMT #MicrobiomeResearch #ChronicIllnessSupport #HopeForIBD #FutureOfMedicine #ClinicalInsights

In this episode of Biome Breakthroughs, we take a deep dive into the world of inflammatory bowel disease (IBD) with a special focus on ulcerative colitis (UC) and explore why fecal microbiota transplantation (FMT) is being called the next big breakthrough in gut health.

For many patients, standard treatments such as steroids, immunosuppressants, and biologics eventually lose their effectiveness or create difficult side effects. But growing research shows that FMT may provide another path forward.

💡 Inside this episode, you’ll learn:

• Why traditional drugs often stop working for UC and Crohn’s patients
• The latest research showing 20%–80% remission rates with FMT in UC
• How longer protocols, donor matching, and oral capsules are improving patient outcomes
• Why monitoring biomarkers like calprotectin and CRP can predict relapses before they happen
• How diet, lifestyle, stress, and sleep can either support or sabotage long-term remission
• A real patient story: a young man with severe UC who avoided surgery, came off biologic, and reached clinical remission after committing to a year-long FMT protocol

This episode is a must-listen for anyone struggling with ulcerative colitis, Crohn’s disease, or IBD as well as clinicians looking to better understand where FMT may fit into the future of treatment.

📩 Reach out at: support@novelbiome.com 🌐 Explore more at www.novelbiome.com 🎧 Subscribe to Biome Breakthroughs for more real conversations about gut science, microbiome medicine, and functional healing.

In the early days, fecal microbiota transplantation (FMT) was done in tiny back-office “labs” with basic tools. Today, advanced donor banks, oral capsules, and extended treatment protocols are transforming outcomes for chronic gut-related conditions.

In this episode of Biome Breakthroughs, we break down exactly how to design an effective FMT protocol from pre-treatment and loading doses to extended maintenance and lifestyle changes. Whether you’re a clinician, researcher, or patient, you’ll learn how tailoring FMT to the condition (and not just copying old C. diff protocols) can be the difference between short-term relief and lasting results.

We cover:

• Why old, short protocols often fail for chronic conditions
• The role of gut “garden prep” before FMT
• How capsules and powders expand treatment options
• Tracking progress and avoiding plateaus
• Lifestyle and diet strategies that keep your microbiome thriving

Watch now to see how FMT has evolved and what it takes to make it truly work.

Why do powerful stem cell therapies lose effectiveness over time? The answer could lie in the gut microbiome.

In this episode of Biome Breakthroughs, we explore the clinical connection between fecal microbiota transplant (FMT) and stem cell therapy, and why these two regenerative approaches may work better together. As gut health becomes a cornerstone of personalized medicine, more researchers and doctors are uncovering the gut’s powerful influence on the immune system, systemic inflammation, and the success of biologic treatments.

You’ll learn:

• How microbiome imbalance (gut dysbiosis) can limit the long-term benefits of stem cell treatments
• Why FMT reduces inflammation, modulates immunity, and creates a more stable biological environment
• What makes gut-brain and gut-immune interactions critical in chronic disease recovery
• How restoring gut integrity may enhance treatment outcomes in autism, autoimmune conditions, cancer, neuroinflammation, and more
• Clinical logic behind adding FMT before stem cells to optimize cellular repair, immune signaling, and therapeutic efficacy
• How leading integrative and functional medicine practitioners are combining therapies to address root causes, not just symptoms

If you're working in longevity medicine, integrative care, or treating complex chronic conditions, this episode is a must-listen for applying a whole-body, systems-based approach to healing.

📩 Reach out at: support@novelbiome.com

🌐 Explore more at www.novelbiome.com

🎧 Subscribe to Biome Breakthroughs for more real conversations about gut science, microbiome medicine, and functional healing.

Disclaimer: Novel Biome is a contract manufacturer of FMT products, providing high-quality FMT products to physicians. The information provided should not be considered medical advice and is based on available research and the understanding of the gut microbiome. If you have more questions, comments or concerns, please email us at support@novelbiome.comisclaimer: Novel Biome is a contract manufacturer of FMT products, providing high-quality FMT products to physicians. The information provided should not be considered medical advice and is based on available research and the understanding of the gut microbiome. If you have more questions, comments or concerns, please email us at support@novelbiome.com